In order to identify the molecular mechanism responsible for the observed therapeutic effect, we first analyzed the mRNA expression of RB and E2F1 24 h after treatment with PD and adenovirus infection (Fig. 4a, b). The gene discussed is E2F1; the disease is adenoviridae infectious disease.